These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26799239)

  • 1. Efficacy of topical tranexmic acid in the treatment of melasma.
    Bagherani N; Smoller BR
    Dermatol Ther; 2016 Nov; 29(6):389-390. PubMed ID: 26799239
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of melasma using tranexamic acid: what's known and what's next.
    Sheu SL
    Cutis; 2018 Feb; 101(2):E7-E8. PubMed ID: 29554171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic treatments for melasma: adjuvant therapy with a novel topical agent.
    Cohen PR
    Int J Dermatol; 2018 Mar; 57(3):e20-e21. PubMed ID: 29313951
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
    Malik F; Hanif MM; Mustafa G
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Tranexamic Acid for the Treatment of Melasma: A Review.
    Bala HR; Lee S; Wong C; Pandya AG; Rodrigues M
    Dermatol Surg; 2018 Jun; 44(6):814-825. PubMed ID: 29677015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical tranexamic acid as an adjuvant treatment in melasma: Side-by-side comparison clinical study.
    Chung JY; Lee JH; Lee JH
    J Dermatolog Treat; 2016 Aug; 27(4):373-7. PubMed ID: 26526300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
    Badran AY; Ali AU; Gomaa AS
    Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral tranexamic acid lightens refractory melasma.
    Tan AWM; Sen P; Chua SH; Goh BK
    Australas J Dermatol; 2017 Aug; 58(3):e105-e108. PubMed ID: 27173008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
    Taraz M; Niknam S; Ehsani AH
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
    Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
    Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
    Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
    Saki N; Darayesh M; Heiran A
    J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of melasma with oral administration of compound tranexamic acid: a preliminary clinical trial.
    Li Y; Sun Q; He Z; Fu L; He C; Yan Y
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):393-4. PubMed ID: 23848176
    [No Abstract]   [Full Text] [Related]  

  • 16. A cross-sectional report on melasma among Hispanic patients: Evaluating the role of oral tranexamic acid versus oral tranexamic acid plus hydroquinone.
    Arreola Jauregui IE; Huerta Rivera G; Soria Orozco M; Meyer-Nava S; Paniagua Santos JE; López Zaldo JB; Meyer-Nava I; Madrid Carrillo C; Zaldo Rolón IE; Baeza Echeverría AE; Vázquez Huerta M
    J Am Acad Dermatol; 2020 Nov; 83(5):1457-1458. PubMed ID: 32151632
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
    Zhu CY; Li Y; Sun QN; Takada A; Kawada A
    Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of functional microarray of microneedles combined with topical tranexamic acid for melasma: A randomized, self-controlled, split-face study.
    Xu Y; Ma R; Juliandri J; Wang X; Xu B; Wang D; Lu Y; Zhou B; Luo D
    Medicine (Baltimore); 2017 May; 96(19):e6897. PubMed ID: 28489798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral tranexamic acid for the treatment of melasma.
    Ali FR
    Clin Exp Dermatol; 2019 Apr; 44(3):347-349. PubMed ID: 30484898
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus.
    Desai S; Chan L; Handog E; Djojoseputro L; Lim J; Ling R; Nguyen H; Tam E; Tang J; Thng S; Tran H
    J Drugs Dermatol; 2023 Apr; 22(4):386-392. PubMed ID: 37026889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.